Buchumschlag

Tumor-associated NK Cells Regulate Distinct CD8+ T-cell Differentiation Program in Cancer and Contribute to Resistance against Immune Checkpoint Blockers.

Fuente: PubMed

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Song, No-Joon, Xie, Juan, Jung, Kyeong Joo, Wang, Yi, Pozniak, Joanna, Roda, Niccolo, Marine, Jean-Christophe, Riesenberg, Brian P, Jeon, Hyeongseon, Ma, Anjun, Cox, Nathanael, Wethington, Darren, Reynolds, Kelsi, Xiao, Tong, Li, Anqi, Kronen, Parker, Denko, Nicholas, Carbone, David P, Ma, Qin, Carson, William E, Mundy-Bosse, Bethany L, Burd, Christin E, Das, Jayajit, Chung, Dongjun, Li, Zihai
Format:	Artículo científico
Sprache:	en
Veröffentlicht:	Cancer discovery 2025
Schlagworte:	Humans CD8-Positive T-Lymphocytes Immune Checkpoint Inhibitors Killer Cells, Natural Cell Differentiation Mice Neoplasms Animals Drug Resistance, Neoplasm Tumor Microenvironment
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Cytotoxic NK Cells Impede Response to Checkpoint Immunotherapy in Melanoma with an Immune-Excluded Phenotype.
von: Pozniak, Joanna, et al.
Veröffentlicht: (2025)

Single-cell mapping of alternative splicing linked to checkpoint immunotherapy response.
von: Xiong, Jieyi, et al.
Veröffentlicht: (2025)

Frontline immunotherapy and immune cold reprogramming across molecular subtypes of advanced endometrial cancer.
von: Lin, Pei-Hsuan, et al.
Veröffentlicht: (2026)

Decoding tumor heterogeneity: A spatially informed pan-cancer analysis of the tumor microenvironment.
von: Lodi, Francesca, et al.
Veröffentlicht: (2025)

Mapping intratumor heterogeneity across layers for advancing immunotherapy.
von: Marine, Jean-Christophe, et al.
Veröffentlicht: (2026)

Revolutionizing cancer treatment: The power of dendritic cell-based vaccines in immunotherapy.
von: Sheykhhasan, Mohsen, et al.
Veröffentlicht: (2025)

Saccharina japonica derived fucoidan potentiates immune checkpoint blockade therapy by modulating the survival and differentiation fate of myeloid-derived suppressor cells.
von: Deng, Zhenzhen, et al.
Veröffentlicht: (2026)

Stromal lipid species dictate melanoma metastasis and tropism.
von: Gurung, Shilpa, et al.
Veröffentlicht: (2025)

State of play in the molecular presentation and recognition of anti-tumor lipid-based analogues.
von: Praveena, T, et al.
Veröffentlicht: (2024)

Decoding melanoma's cellular mosaic to unlock immunotherapy potential.
von: Pozniak, Joanna, et al.
Veröffentlicht: (2025)

Recent advances in targeting cancer stem cells by using nanomaterials.
von: Rahimkhoei, Vahid, et al.
Veröffentlicht: (2025)

Low-molecular-weight polyphenol promotes cell sensitivity to cisplatin and alleviates cancer-related muscle atrophy via NF-κB suppression in oral squamous cell carcinoma.
von: Chang, Yun-Ching, et al.
Veröffentlicht: (2025)

Potentiating immunotherapy in "immune-cold" solid tumors through orchestrating T cell immunity via tumor-specific genetic engineering.
von: He, Jiaqi, et al.
Veröffentlicht: (2025)

Bacterial Foreignization Nanosystem Elicits Multi-Phenotypic T Cells for Antitumor Immunity.
von: Zhuang, Wan-Ru, et al.
Veröffentlicht: (2025)

SBRT embedded in low-dose RT plus αPD-1 (immuno-EclipseRT, iERT) elicits CD8+ T cell immunity against bulky tumors via an IFN-I/NK/DC axis
von: Luo, Ren, et al.
Veröffentlicht: (2025)

A Physical Framework to Control Cancer Cell Heterogeneity and Plasticity.
von: De Blander, Hadrien, et al.
Veröffentlicht: (2026)

Synergistic induction of immunogenic cell death and tumor microenvironment remodeling by biotinylated marine polysaccharide nanoparticles for enhanced colorectal cancer therapy.
von: Wang, Hui, et al.
Veröffentlicht: (2026)

Preliminary Insights Into the Combined Antitumor Efficacy of Onco-VV-TT and Natural Killer Cells in Glioblastoma.
von: Mirbahari, Seyedeh Nasim, et al.
Veröffentlicht: (2026)

A Multisynergistic Strategy for Bone Tumor Treatment: Orchestrating Oxidative Stress and Autophagic Flux Inhibition by Environmental-Response Nanoparticle.
von: Chen, Xiaochen, et al.
Veröffentlicht: (2025)

Bicytopenia and leukoerythroblastosis: a rare initial presentation of signet ring cell gastric adenocarcinoma
von: Vilma Takayasu
Veröffentlicht: (2017)

Apratoxin S10 as a dual-action modulator of receptor tyrosine kinases and tumor microenvironment: emerging anticancer insights from marine-derived analogs.
von: Dhyani, Praveen, et al.
Veröffentlicht: (2025)

Potential anticancer properties of Tetraselmis suecica extract against oral and colorectal cancer cells.
von: Asoudeh-Fard, Abbas, et al.
Veröffentlicht: (2025)

Apigenin Induces Autophagy and Apoptosis in Chemoresistant Glioblastoma Cells and Inhibits Tumorigenicity Associated with Regulation of Immunomodulatory Proteins and Glial Cells Response.
von: Coelho, Paulo Lucas Cerqueira, et al.
Veröffentlicht: (2025)

NF-kappa-B inhibitor alpha mediates cancer stemness characteristics in oral squamous cell carcinoma by interacting with cathepsin B.
von: Qin, Tian Xu, et al.
Veröffentlicht: (2025)

Clear cell variant of oral squamous cell carcinoma: case report and review
von: Rutuja Narsing Mukkanwar
Veröffentlicht: (2022)

LED blue light photobiomodulation induces ferroptosis and apoptosis via ROS-mediated oxidative damage in osteosarcoma cells.
von: Yang, Jiali, et al.
Veröffentlicht: (2026)

BIT1 as an Effector of EGFR-TKI-induced Apoptosis TLE1 Inhibition in Lung Adenocarcinoma Cells.
von: Dela Cruz, Ma Carmela, et al.
Veröffentlicht: (2026)

The Immune Barrier Atlas: Cancer-Type-Specific Resistance Mechanisms Across 33 Tumor Types and Their Matched Drug Classes
von: van der Klein, Raimo
Veröffentlicht: (2026)

The Immune Barrier Atlas: Cancer-Type-Specific Resistance Mechanisms Across 33 Tumor Types and Their Matched Drug Classes
von: van der Klein, Raimo
Veröffentlicht: (2026)

MSR1 in lung squamous cell carcinoma: Prognostic and immunological values in pan-cancer and single-cell analyses and a cohort study.
von: Bu, Yuxiang, et al.
Veröffentlicht: (2025)

Discovery of the First-in-Class Dual-Target ROCK/HDAC Inhibitor with Potent Antitumor Efficacy in Vivo That Trigger Antitumor Immunity.
von: Mao, Churu, et al.
Veröffentlicht: (2024)

Label-free Single Cell Phenotyping to Determine Tumor Cell Heterogeneity in Pancreatic Cancer in Real-time
von: Peschke, Katja
Veröffentlicht: (2025)

Ultrasonication-assisted green synthesis, in silico EGFR-binding analysis, and cytotoxic evaluation of nitro-perimidines for non-small cell lung cancer.
von: Gopinadh, Meera, et al.
Veröffentlicht: (2026)

The roles of algal polysaccharides in modulating tumor immune microenvironment.
von: Wu, Yinfeng, et al.
Veröffentlicht: (2025)

The Potent Antioxidant 3,5-Dihydroxy-4-Methoxybenzyl Alcohol Reveals Anticancer Activity by Targeting Several Signaling Pathways in Bone Metastatic Human Breast Cancer MDA-MB-231 Cells.
von: Yamaguchi, Masayoshi, et al.
Veröffentlicht: (2025)

Sun Exposure and Skin Cancer: A Narrative Review of Risk Factors, Prevention Behaviors, and Emerging Therapeutic Approaches
von: Silva, Luiz Felipe Rodrigues, et al.
Veröffentlicht: (2026)

Activated T Cells Break Tumor Immunosuppression by Macrophage Reeducation.
von: Trotta, Rosa, et al.
Veröffentlicht: (2025)

GIANT CELL TUMOR OF THE DORSAL VERTEBRAE. CASE REPORT
von: Lúver Alexi Macías-Jara
Veröffentlicht: (2019)

Occult esophageal squamous cell carcinoma with metastases to the spine and central nervous system
von: Ana Lídia Viaro
Veröffentlicht: (2015)

Tumor Microenvironment-Responsive Multinucleated Nanocomplexes Loaded with Carbon Dots for Combined Photothermal/Chemodynamic Therapy of Breast Cancer.
von: Zhu, Zihan, et al.
Veröffentlicht: (2025)